INX IMCD N.V.

IMCD reports 46% EBITA growth in the first half of 2021

IMCD reports 46% EBITA growth in the first half of 2021

Rotterdam, The Netherlands (4 August 2021) - IMCD N.V. ("IMCD" or "Company"), a leading distributor of speciality

chemicals and ingredients, today announces its first half year 2021 results.

HIGHLIGHTS

• Gross profit growth of 23% to EUR 410.9 million (+28% on a constant currency basis)

• Operating EBITA increase of 46% to EUR 192.3 million (+52% on a constant currency basis)

• Net result before amortisation and non-recurring items increase of 52% to EUR 137.5 million (+57% on a constant

currency basis)

• Cash earnings per share increased by 44% to EUR 2.43 (first half of 2020: EUR 1.69)

• In the second quarter of 2021, IMCD completed the acquisitions of Siliconas in Colombia, Andes Chemical in the

US, Colombia and Peru and Yuanhe Chemicals in China

Piet van der Slikke, CEO: "We are reporting very strong results for the first six months of the year. After a promising

start of the year, the positive momentum continued into the second quarter and our teams across all regions were able

to benefit optimally from the strong product demand. This has resulted in double digit growth numbers, with gross

profit being up 23% (+28% on a constant currency basis), and operating EBITA being up 46% (+52% on a constant

currency basis). All regions achieved substantial organic growth and contributed to the overall positive results. It

remains to be seen how the pandemic will influence the current economic conditions, but we are optimistic that we

can further execute our growth strategy successfully in the remainder of the year."

Attached, please find the full press release.

Attachment



EN
04/08/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IMCD N.V.

 PRESS RELEASE

IMCD to acquire Dong Yang FT to strengthen position in beauty and pers...

IMCD to acquire Dong Yang FT to strengthen position in beauty and personal care in South Korea Rotterdam, The Netherlands (16 October 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, has signed an agreement to acquire 100% of the shares in Dong Yang FT Corp. ("Dong Yang FT"). Founded in 2009 and based in Seoul, South Korea, Dong Yang FT is a distributor of high-quality cosmetic ingredients, working with cosmetic manufacturers across the beauty and personal care sector. With a team of 14 people an...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ageas: 1H leads to increase in 2025 net result guidance, but also FCF. IMCD: Material acquisition in Italy. Kendrion: Unlocking value, sells Chinese business at high multiple. Retail Estates: Limited impact of Leen Bakker judicial reorganization

Guy Sips ... (+6)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Lewi

Morning Notes : AGS BB, AGFB BB, IVA FP, RET BB, TWEKA NA, VAN BB, NXF...

: AGS BB, AGFB BB, IVA FP, RET BB, TWEKA NA, VAN BB, NXFIL NA, IMCD NA

 PRESS RELEASE

IMCD to acquire Tillmanns to further strengthen its presence in Italy

IMCD to acquire Tillmanns to further strengthen its presence in Italy Rotterdam, The Netherlands (27 August 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, has signed an agreement to acquire 100% of the shares in Tillmanns S.p.A. (“Tillmanns”). Founded in 1940 and headquartered in Milan, Italy, Tillmanns is a well-established distributor of specialty chemicals, acting as a key partner for global suppliers and a broad base of customers. With operations strongly anchored in Italy, the company oper...

IMCD NV: 1 director

A director at IMCD NV bought 1,000 shares at 99.100EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch